Clinical pathways for managing patients receiving interleukin 2.

Clinical journal of oncology nursing

Volumn 5, Issue 5, 2001, Pages 207-217

  Mavroukakis, S A ^a   Muehlbauer, P M ^a   White Jr , R L ^a   Schwartzentruber, D J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 2;

CLINICAL PATHWAY; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; KIDNEY CARCINOMA; KIDNEY TUMOR; MELANOMA; METASTASIS; PHYSIOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CRITICAL PATHWAYS; HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; INTERLEUKIN-2; KIDNEY NEOPLASMS; MELANOMA;

EID: 0035469327     PISSN: 10921095     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)